Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
2023 · Cancer Cell · 216 citations
https://doi.org/10.1016/j.ccell.2023.08.002
D
Daniel Schmolze
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
814
Citations
14
h-index
16
i10-index
Daniel Schmolze is an academic researcher from City Of Hope National Medical Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Advanced Breast Cancer Therapies & Cancer Genomics and Diagnostics. The author has an h-index of 14, co-authored 80 publications.
Papers by this author
worksTowards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer
2020 · Scientific Reports · 37 citations
https://doi.org/10.1038/s41598-020-77397-0
Accuracy of gross intraoperative margin assessment for breast cancer: experience since the SSO-ASTRO margin consensus guidelines
2020 · Scientific Reports · 31 citations
https://doi.org/10.1038/s41598-020-74373-6
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer
2021 · Journal for ImmunoTherapy of Cancer · 31 citations
https://doi.org/10.1136/jitc-2020-002084
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer
2022 · Cancers · 23 citations
https://doi.org/10.3390/cancers14133159
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
2023 · Cancer Immunology Immunotherapy · 18 citations
https://doi.org/10.1007/s00262-023-03470-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat